IM Cannabis (IMCC) Acquisitions (2021)
IM Cannabis (IMCC) recorded quarterly Acquisitions of -$4.5 million in Q4 2021, down 1675.49% quarter-over-quarter from $286015.9 in Q1 2021.
IM Cannabis (IMCC) Acquisitions (2021) Analysis & Trends
IM Cannabis' Acquisitions history runs 1 years deep, the most recent figure standing at -$4.5 million for Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 2.09 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 137.87 Mn |
| 10 | IM Cannabis | 57,090.22 | -728,264.31 | 1.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -4.51 Mn |
| Mar 31, 2021 | 286,015.88 |